- Case report
- Open Access
- Open Peer Review
A case report of primary cardiac myxofibrosarcoma presenting with severe congestive heart failure
© The Author(s). 2016
- Received: 18 March 2016
- Accepted: 24 June 2016
- Published: 7 July 2016
Primary cardiac sarcomas are extremely rare. Furthermore, the myxofibrosarcomas are one of the rarest forms of cardiac sarcomas, and its prognosis is known to be quite poor.
This is a case of a 23-year-old man who presented with acute severe congestive heart failure caused by almost complete obstruction of the mitral valve due to a large left atrial tumor. The patient required endotracheal intubation before his arrival to the hospital, and underwent an emergent surgical excision of the tumor. The tumor had a complex shape and originated from the orifice of the right upper pulmonary vein. Because the tumor seemed to extend over most of the surface of the left atrium, it seemed impossible to reconstruct the left atrium had we done a complete transmural resection. Instead, we carefully peeled the tumor leaving the outer layer of the left atrial wall. We applied cryoablation to the attached site, in order to prevent a recurrence of the tumor. The pathology report revealed that the tumor was a myxofibrosarcoma, and it seemed to originate from the heart. The patient received radiation therapy after the surgery and continues to be alive and well after 1-year, without apparent recurrence.
Cardiac myxofibrosarcoma can cause acute, severe left-sided heart failure. Non-transmural atrial wall resection with cryoablation might be effective for patients with cardiac myxofibrosarcomas with extensive atrial attachment.
- Cardiac tumor
- Heart failure
The majority of cardiac tumors are benign, and approximately half of them are myxomas . Primary cardiac sarcomas are rare malignant primary tumors of the heart, accounting for about 20 % of all primary cardiac tumors . Myxofibrosarcomas are reported as one of the rarest forms of cardiac sarcomas . The clinical presentation depends on the site of the tumor and it varies from symptoms of congestive heart failure to thromboembolism and arrhythmias [3–6]. In this report, we present a 23-year-old man who presented with symptoms and signs of acute severe left-sided heart failure, requiring an emergent endotracheal intubation followed by cardiac surgery, caused by a primary cardiac myxofibrosarcoma in the left atrium.
A 23-year-old man called for an ambulance due to a sudden onset of severe dyspnea. He had 1-year history of general malaise without a major change in his weight or other health problems. At age 13, he had been diagnosed with Asperger syndrome for which he received pharmacological treatment and psychiatric supervision. Otherwise, he was a healthy young man.
After the tumor resection, we identified a mitral valve annular enlargement with severe regurgitation, which was probably caused by the prolapse of the large tumor across the valve. We performed a mitral valve annuloplasty with a Physio II ring (Edwards Lifesciences Corp. Irvine, CA, USA) with satisfactory results. The surgery ended safely without major complications or need for transfusions.
Immunohistochemical tests showed a weak immunoreactivity for calponin, and patchy positivity for CD34. It was negative for CD31, Factor VIII, desmin, myogenin, MyoD1, h-caldesmon, S-100 protein, CAM5.2 and AE1/AE3. The tumor cells showed focal myofibroblastic differentiation. Therefore, the final diagnosis was myxofibrosarcoma. The possibilites of angiosarcoma or leiomyosarcoma were ruled-out by the histological and immunohistochemical features.
The patient was discharged on post-operative day 10 without complications. A magnetic resonance imaging (MRI) of the brain and an enhanced whole body CT were negative for metastatic disease.
Upon discharge, the patient was referred to a local cancer center where he later received radiotherapy for 2 weeks, as adjuvant therapy. His postoperative treatment was completed successfully, and 1-year later he remains asymptomatic without apparent recurrence. A transthoracic echocardiogram 14 months after the surgery was normal.
A left atrial sarcoma is an extremely rare cardiac tumor, generally with poor prognosis . One-quarter of all primary cardiac tumors are malignant; approximately 95 % are sarcomas and 5 % are lymphomas. Sarcomas of the heart usually occur in the 3rd or 5th decade of life, and are seen with equal frequency in males and females .
A myxofibrosarcoma is a tumor of mesenchymal origin that occurs most commonly in the extremities of elderly patients . Primary myxofibrosarcomas rarely arise in the heart, and they may involve any of the four cardiac chambers, but it most frequently affects the left atrium . Because the primary myxofibrosarcoma is capable of local invasion or distant metastasis, the prognosis of patients has been reported to be very poor despite surgical resection, radiation therapy, and chemotherapy .
Cardiac tumors have a variable clinical presentation that includes obstruction to blood flow, embolism and local invasion, resulting in pericardial effusion, arrhythmias or systemic symptoms .
A cardiac sarcoma located in the left atrium can cause obstruction of the mitral valve and cause symptoms of mitral stenosis such as dyspnea, cough, hemoptysis, and fatigue, all of which have been reported previously . When the tumors are suspected to incarcerate in the mitral orifice, they require emergent surgery . To the best of our knowledge, there are no previous reports of severe acute congestive heart failure caused by a myxofibrosarcoma, requiring an emergent endotracheal intubation and operation.
Sarcomas are aggressive tumors with an average survival of approximately 11 months. The most important factor that predicts a better prognosis is the ability to achieve a complete surgical resection of the tumor. Life expectancy is nearly twice as long for patients in whom complete tumor resection is achieved, compared with patients who undergo incomplete excision . Hence, surgery is the mainstay of treatment for these lesions, and to date, the extent to which adjuvant chemotherapy and radiation therapy are beneficial, remains controversial. Burke et al.  reported 75 cases of primary sarcomas of the heart with better survival rates in the patients who received chemotherapy and radiotherapy. Repeat surgical interventions are reported to be effective, with the patient maintaining a good quality of life between surgical events .
Complete resection of the malignant tumor is ideal, however, large tumors with a broad stalk attached to the atrium could make the reconstruction of the atrial wall difficult . Unfortunately, our patient had a quite broad tumor stalk, which extended over most of the left atrial surface. Because of the severity of his presentation, we were unable to perform an extensive preoperative examination or planning. It was also mandatory to finish the surgery as soon as possible to decrease his surgical stress. Therefore, we performed a non-transmural atrial wall resection leaving pericardium, with cryoablation on its stalk near the right upper pulmonary vein. This operation might be useful for intimal cardiac tumors only and should not be performed for tumors arising from the pericardium including metastasis. Fortunately in this case, the pathology revealed that the tumor was not a metastasis, so we decided not to add a secondary surgical intervention in the acute post-operative phase. Due to the possibility of incomplete resection of the tumor, we recommended adjuvant radiation therapy along with follow-up echocardiograms every 3 months.
In summary, primary cardiac sarcomas are rare malignant tumors of the heart with poor prognosis. Clinical features depend on the site of the tumor and may include severe acute left sided heart failure for which emergent tracheal intubation is necessary. Complete surgical resection provides the greatest chance for survival; however, non-transmural atrial wall resection with cryoablation might be effective for patients with extensive atrial attachment. Careful follow-up is necessary to detect recurrences.
CT, computed tomography; LA, left atrial; PV, pulmonary vein
The authors greatly appreciate Shadia Constantine, MD, FACP, MPH, for her help in correcting the manuscript.
KU performed the surgery and wrote this paper. AY and KN joined the operation. AS, KCH, TM, TS and HIU conducted the pathological studies and contributed to make the diagnosis. NN, YI and RM contributed to the peri-operative management of the patient. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of this report and any accompanying images.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Silverman NA. Primary cardiac tumors. Ann Surg. 1980;191(2):127–38.View ArticlePubMedPubMed CentralGoogle Scholar
- Orlandi A et al. Cardiac sarcomas: an update. J Thorac Oncol. 2010;5(9):1483–9.View ArticlePubMedGoogle Scholar
- Centofanti P et al. Primary cardiac tumors: early and late results of surgical treatment in 91 patients. Ann Thorac Surg. 1999;68(4):1236–41.View ArticlePubMedGoogle Scholar
- Pathak R, et al. Primary cardiac sarcoma presenting as acute left-sided heart failure. J Community Hosp Intern Med Perspect. 2014;4(3). doi:10.3402/jchimp.v4.23057.
- Kuurstra EJ, Mullen JC, MacArthur RG. Massive left atrial sarcoma presenting with severe congestive heart failure. Can J Cardiol. 2014;30(10):1250. e13-5.View ArticlePubMedGoogle Scholar
- Abe D et al. Life-threatening acute heart failure due to primary cardiac undifferentiated pleomorphic sarcoma. Intern Med. 2014;53(16):1775–7.View ArticlePubMedGoogle Scholar
- Sarjeant JM, Butany J, Cusimano RJ. Cancer of the heart: epidemiology and management of primary tumors and metastases. Am J Cardiovasc Drugs. 2003;3(6):407–21.View ArticlePubMedGoogle Scholar
- Shapiro LM. Cardiac tumours: diagnosis and management. Heart. 2001;85(2):218–22.View ArticlePubMedPubMed CentralGoogle Scholar
- Mentzel T et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol. 1996;20(4):391–405.View ArticlePubMedGoogle Scholar
- Lazaros GA et al. Primary myxofibrosarcoma of the left atrium: case report and review of the literature. Angiology. 2008;59(5):632–5.View ArticlePubMedGoogle Scholar
- Butany J et al. Cardiac tumours: diagnosis and management. Lancet Oncol. 2005;6(4):219–28.View ArticlePubMedGoogle Scholar
- Burke AP, Cowan D, Virmani R. Primary sarcomas of the heart. Cancer. 1992;69(2):387–95.View ArticlePubMedGoogle Scholar